Real-world data services that transform interactions into evidence
Bridging the real-world data gap in biopharma
Across Europe, capturing reliable real-world data is complex. Fragmented health systems, inconsistent reporting and limited patient visibility make it difficult to generate actionable evidence.
Sciensus addresses these challenges. With over 30 years of patient engagement and an integrated network spanning logistics, nursing and digital tools, we offer real-world data services to generate high-quality, compliant insights directly from patients in their real-world settings.
Unmatched patient access
Integrated European infrastructure
Regulatory and local market expertise
Prove value and performance
Accelerate access and adoption
Improve adherence and outcomes
Evidence generation throughout the drug life cycle
Sciensus real-world data is sourced from our interactions with millions of patients. From the personal touch of in-home nursing care to patient engagement on the proprietary Intouch app, Sciensus has access to patients to collect timely and accurate data on dosing, safety and effectiveness, and adherence.
Learn about how our real-world data services can fill the gaps left by clinical trials and boost your chances of success here.
-
End-to-end study management
-
Real-world evidence insights
-
Direct patient engagement
Case study: generating real-world evidence that supports market access
Read about how Sciensus has been involved in generating real-world evidence for UK patients receiving complex, specialist treatment at home, aimed at providing context on how therapy is used in practice, how people respond to it over long periods and when additional support is needed.
Advance treatment value through real-world evidence
Real-world data (RWD) is reshaping the pharmaceutical landscape. Unlike controlled clinical trials, RWD captures how treatments perform in real patient populations, incorporating adherence, comorbidities and demographic diversity. From electronic health records and insurance claims to wearable devices and patient-reported outcomes, these insights form the foundation of real-world evidence (RWE).
RWE is critical for demonstrating treatment safety, effectiveness and value in everyday practice. It underpins regulatory submissions, supports payer negotiations, informs clinical decision-making and guides long-term treatment strategies.
Sciensus is uniquely positioned to generate these insights. Trusted daily to engage patients across Europe, we combine digital solutions, therapeutic expertise and a comprehensive logistics network to deliver meaningful evidence for your brand’s success.
Frequently asked questions
What is real-world data (RWD) in healthcare?
RWD refers to health-related data collected outside controlled clinical trials – from patient records, claims data, registries, wearables and patient-reported outcomes.
How does real-world evidence (RWE) differ from RWD?
RWD is the raw data collected from diverse sources, while RWE is the analysis and insights derived from that data to answer specific clinical or commercial questions.
Why is real-world evidence important for biopharma companies?
RWE supports regulatory approvals, payer negotiations, post-marketing surveillance and demonstrates treatment value in everyday practice – ultimately helping brands achieve faster adoption and better outcomes.
How can Sciensus support my company’s RWE needs?
We provide end-to-end study management, patient engagement, data integration and therapeutic expertise to deliver high-quality, actionable insights across Europe.
What makes Sciensus different from other PSP providers?
Our scale, experience and connected ecosystem across Europe – combined with digital innovation and end-to-end expertise – ensure measurable impact for both patients and pharma partners.
Meet our real-world data expert
Get in touch
Thank you for your interest in Sciensus. Whether you’re seeking information, partnership opportunities, or want to refer a patient, our dedicated team is here to assist you. Please fill out the form on the right, and one of our multi-lingual representatives will get in touch with you promptly.